What is Arbor Assays?
Arbor Assays operates at the intersection of biotechnology and laboratory research, providing a comprehensive suite of high-quality assay and enzyme activity kits. The company has carved out a distinct niche by delivering reliable, user-friendly testing solutions, including ELISA kits tailored for the precise measurement of hormones and metabolites. By serving a diverse ecosystem that spans academic research institutions, biotechnology firms, and specialized wildlife organizations such as zoos and aquariums, Arbor Assays ensures that critical scientific data remains accessible and accurate. Their commitment to rigorous testing standards positions them as a vital partner for organizations dedicated to advancing biological and environmental studies through precise metabolic analysis.
How much funding has Arbor Assays raised?
Arbor Assays has raised a total of $310K across 2 funding rounds:
Debt
$150K
Debt
$160K
Debt (2020): $150K with participation from PPP
Debt (2021): $160K led by PPP
Key Investors in Arbor Assays
PPP
Public-Private Partnership
What's next for Arbor Assays?
Following this latest capital injection, Arbor Assays is well-positioned to scale its research and development initiatives, potentially expanding its catalog of diagnostic tools to meet emerging market demands. The strategic focus will likely shift toward enhancing manufacturing efficiencies and broadening the reach of their assay platforms into new international research markets. As the company navigates this late-stage growth phase, the emphasis remains on maintaining the high-fidelity performance of their kits while exploring new applications for their proprietary enzyme activity technologies. This financial backing provides the necessary runway to accelerate product innovation and strengthen the company's infrastructure, ensuring that Arbor Assays remains a cornerstone provider for the global scientific community.
See full Arbor Assays company page
